BIOMAT Database Logo BIOMAT Database Logo

High-density lipoproteins after acute coronary syndromes: evaluation of residual risk. 2013

Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D054058 Acute Coronary Syndrome An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION. Acute Coronary Syndromes,Coronary Syndrome, Acute,Coronary Syndromes, Acute,Syndrome, Acute Coronary,Syndromes, Acute Coronary

Related Publications

Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
[Residual risk: The roles of triglycerides and high density lipoproteins].
June 2016, Deutsche medizinische Wochenschrift (1946),
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
[High density lipoproteins, diabetes, alcohol consumption and coronary risk].
November 1979, Medicina clinica,
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
Reduced high density lipoproteins as a risk factor after acute myocardial infarction.
January 1987, Acta medica Scandinavica,
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
Risk factor management after acute coronary syndromes.
September 2009, Heart (British Cardiac Society),
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
[High-density lipoproteins and coronary arteriosclerosis].
January 1980, Zdravookhranenie Kirgizii,
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
Acute coronary syndromes: initial evaluation and risk stratification.
January 2004, Progress in cardiovascular diseases,
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
High density lipoproteins, insulin secretion and coronary risk factors in latent coronary insufficiency.
November 1979, Scandinavian journal of clinical and laboratory investigation,
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
Redefining residual inflammatory risk after acute coronary syndrome.
February 2022, Future cardiology,
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
Soluble CD40L: risk prediction after acute coronary syndromes.
September 2003, Circulation,
Lorenzo Fácila, and Julio Núñez, and Juan Sanchis, and Alberto Cordero, and Oscar Fabregat-Andrés, and Salvador Morell
Diabetes and mortality risk after acute coronary syndromes.
November 2007, JAMA,
Copied contents to your clipboard!